BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35550984)

  • 1. Arsenic exposures and prostate cancer risk: A multilevel meta-analysis.
    Yang Y; McDonald AC; Wang X; Pan Y; Wang M
    J Trace Elem Med Biol; 2022 Jul; 72():126992. PubMed ID: 35550984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-level arsenic exposure from drinking water is associated with prostate cancer in Iowa.
    Roh T; Lynch CF; Weyer P; Wang K; Kelly KM; Ludewig G
    Environ Res; 2017 Nov; 159():338-343. PubMed ID: 28841521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS; Alexander DD; Perez V; Mink PJ
    Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of urinary tract cancers following arsenic exposure and tobacco smoking: a review.
    Baghery F; Lau LDW; Mohamadi M; Vazirinejad R; Ahmadi Z; Javedani H; Eslami H; Nazari A
    Environ Geochem Health; 2023 Aug; 45(8):5579-5598. PubMed ID: 37248359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Yang et al., Arsenic exposures and prostate cancer risk: A multilevel meta-analysis [J. Trace Elem. Med. Biol. (2022) 72 126992].
    Boffetta P; Collatuzzo G; Cohen SM
    J Trace Elem Med Biol; 2023 Jul; 78():127191. PubMed ID: 37163820
    [No Abstract]   [Full Text] [Related]  

  • 6. Ambient air exposures to arsenic and cadmium and overall and prostate cancer-specific survival among prostate cancer cases in Pennsylvania, 2004 to 2014.
    McDonald AC; Gernand J; Geyer NR; Wu H; Yang Y; Wang M
    Cancer; 2022 May; 128(9):1832-1839. PubMed ID: 35195279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic arsenic and human prostate cancer.
    Benbrahim-Tallaa L; Waalkes MP
    Environ Health Perspect; 2008 Feb; 116(2):158-64. PubMed ID: 18288312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Incidence in U.S. Counties and Low Levels of Arsenic in Drinking Water.
    Ahn J; Boroje IJ; Ferdosi H; Kramer ZJ; Lamm SH
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033184
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasectomy and prostate cancer risk: a meta-analysis of prospective studies.
    Cheng S; Yang B; Xu L; Zheng Q; Ding G; Li G
    Carcinogenesis; 2021 Feb; 42(1):31-37. PubMed ID: 32772072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.
    Dai X; Fang X; Ma Y; Xianyu J
    Medicine (Baltimore); 2016 May; 95(18):e3493. PubMed ID: 27149447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of inorganic arsenic exposure with liver cancer mortality: A meta-analysis.
    Wang W; Cheng S; Zhang D
    Environ Res; 2014 Nov; 135():120-5. PubMed ID: 25262084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legume intake and risk of prostate cancer: a meta-analysis of prospective cohort studies.
    Li J; Mao QQ
    Oncotarget; 2017 Jul; 8(27):44776-44784. PubMed ID: 28423366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic in drinking water and prostate cancer in Illinois counties: An ecologic study.
    Bulka CM; Jones RM; Turyk ME; Stayner LT; Argos M
    Environ Res; 2016 Jul; 148():450-456. PubMed ID: 27136670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is use of vitamin K antagonists associated with the risk of prostate cancer?: A meta-analysis.
    Luo JD; Luo J; Lai C; Chen J; Meng HZ
    Medicine (Baltimore); 2018 Dec; 97(49):e13489. PubMed ID: 30544443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sedentary Behavior and Prostate Cancer: A Systematic Review and Meta-Analysis of Prospective Cohort Studies.
    Berger FF; Leitzmann MF; Hillreiner A; Sedlmeier AM; Prokopidi-Danisch ME; Burger M; Jochem C
    Cancer Prev Res (Phila); 2019 Oct; 12(10):675-688. PubMed ID: 31362941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis.
    Simon JA; Chen YH; Bent S
    Am J Clin Nutr; 2009 May; 89(5):1558S-1564S. PubMed ID: 19321563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Risk for Prostate Cancer With Calcium Channel Blockers: A Systematic Review, Meta-Analysis, and Meta-Regression.
    Rotshild V; Rabkin N; Matok I
    Ann Pharmacother; 2023 Jan; 57(1):16-28. PubMed ID: 35645169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult weight gain and risk of prostate cancer: A dose-response meta-analysis of observational studies.
    Chen Q; Chen T; Shi W; Zhang T; Zhang W; Jin Z; Wei X; Liu Y; He J
    Int J Cancer; 2016 Feb; 138(4):866-74. PubMed ID: 26356247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between shift work and risk of prostate cancer: a systematic review and meta-analysis of observational studies.
    Gan Y; Li L; Zhang L; Yan S; Gao C; Hu S; Qiao Y; Tang S; Wang C; Lu Z
    Carcinogenesis; 2018 Feb; 39(2):87-97. PubMed ID: 29126152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and risk of prostate cancer: a systematic review and meta-analysis.
    Liang Z; Xie B; Li J; Wang X; Wang S; Meng S; Ji A; Zhu Y; Xu X; Zheng X; Xie L
    Sci Rep; 2016 Aug; 6():31358. PubMed ID: 27511796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.